Yearly license (maintenance fee and IND filing fee) to use a monoclonal antibody produced via atum proprietary cell line technology
Active Purchase Order Awarded Last action
- Contract number
- 75N93023P00594
- Awardee
-
DNA Twopointo Inc. UEI G9S3SC8T5DM1
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Opportunity
-
- License Renewal for Protein Expressing Cell Line Pre-Solicitation · NOINIAID232168820 · Posted Apr 13, 2023
- Contract value 80% obligated
-
- $300,000.00 Current, with exercised options
- $375,000.00 Potential, with all options
- Completion date 69% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Newark, CA 94560, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $75,000 | |
| Exercise an Option | $75,000 | |
| Exercise an Option | $75,000 | |
| Original award | $75,000 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a purchase order to DNA Twopointo Inc. (doing business as ATUM Biosciences) for a yearly license to use a monoclonal antibody produced via the company's proprietary cell line technology, with a ceiling value of $375,000 and an award date of May 14, 2023.
Performance occurs in Newark, California. The license supports ongoing AIDS clinical trials and includes ATUM's Leap-In Transposon technology, which accelerates generation of stable cell pools and lines. The order covers maintenance fees and industrial filing fees. Ultimate completion is scheduled for May 13, 2028. The originating pre-solicitation notice, posted April 13, 2023, indicated the agency's intent to award on a sole source basis; the notice characterized the annual license value as $1 million to $5 million depending on clinical trial needs.
Quick answers
Who was awarded contract 75N93023P00594?
75N93023P00594 was awarded to DNA Twopointo Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 14, 2023.
How much is contract 75N93023P00594 worth?
The government has obligated $300,000 on 75N93023P00594. Its potential value, with all options, is $375,000.
Was contract 75N93023P00594 competed?
The extent of competition for 75N93023P00594 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award